ATE211921T1 - Verwendung von gonadotropin zur behandlung der gestartigen hypertrophie der prostata - Google Patents
Verwendung von gonadotropin zur behandlung der gestartigen hypertrophie der prostataInfo
- Publication number
- ATE211921T1 ATE211921T1 AT96937823T AT96937823T ATE211921T1 AT E211921 T1 ATE211921 T1 AT E211921T1 AT 96937823 T AT96937823 T AT 96937823T AT 96937823 T AT96937823 T AT 96937823T AT E211921 T1 ATE211921 T1 AT E211921T1
- Authority
- AT
- Austria
- Prior art keywords
- gonadotropin
- treatment
- benign prostatic
- prostatic hypertrophy
- prostate hypertrophy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/593,501 US5610136A (en) | 1996-01-30 | 1996-01-30 | Method for treatment of benign prostatic hypertrophy |
PCT/US1996/017421 WO1997027869A1 (en) | 1996-01-30 | 1996-10-30 | Method for treatment of benign prostatic hypertrophy |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE211921T1 true ATE211921T1 (de) | 2002-02-15 |
Family
ID=24374964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96937823T ATE211921T1 (de) | 1996-01-30 | 1996-10-30 | Verwendung von gonadotropin zur behandlung der gestartigen hypertrophie der prostata |
Country Status (8)
Country | Link |
---|---|
US (1) | US5610136A (de) |
EP (1) | EP0817645B1 (de) |
JP (1) | JP2971950B2 (de) |
AT (1) | ATE211921T1 (de) |
AU (1) | AU705524B2 (de) |
CA (1) | CA2216810C (de) |
DE (1) | DE69618578T2 (de) |
WO (1) | WO1997027869A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6319504B1 (en) * | 1996-06-24 | 2001-11-20 | University Of Maryland Biotechnology Institute | Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin |
US6583109B1 (en) | 1997-06-24 | 2003-06-24 | Robert C. Gallo | Therapeutic polypeptides from β-hCG and derivatives |
US7994278B1 (en) | 1999-08-06 | 2011-08-09 | Nobel Biosciences Llc | Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA) |
US7101847B2 (en) * | 2002-10-11 | 2006-09-05 | Milkhaus Laboratory, Inc. | Method of treating chronic pelvic pain syndrome by administration of chorionic gonadotropin |
EP1480631B1 (de) * | 2002-12-20 | 2007-08-01 | Dynogen Pharmaceuticals Inc. | Behandlung nicht-schmerzhafter blasenstörungen mit modulatoren von alpha-2-delta- calciumkanaluntereinheiten |
ATE345120T1 (de) * | 2003-03-21 | 2006-12-15 | Dynogen Pharmaceuticals Inc | Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals |
US7605122B2 (en) | 2005-07-29 | 2009-10-20 | Millennium Medical Spa | Human chorionic gonadotropin (hCG) formulations for facilitating weight loss and body contouring |
WO2007035395A2 (en) * | 2005-09-16 | 2007-03-29 | Virginia Commonwealth University Intellectual Property Foundation | Therapeutic compositions comprising chorionic gonadotropins and hmg coa reductase inhibitors |
US9707403B2 (en) | 2007-12-12 | 2017-07-18 | Neuro Code Tech Holdings, Llc | Rapid destruction of malignant tumors by excitotoxicity and osmotic-shock medical tactics |
WO2009089517A1 (en) | 2008-01-10 | 2009-07-16 | The Neuro-Signaling Foundation | Method and system for processing cancer cell electrical signals for medical therapy |
US8831738B2 (en) | 2008-04-17 | 2014-09-09 | Neuro Code Tech Holdings, Llc | System and method to elicit apoptosis in malignant tumor cells for medical treatment |
WO2010033207A1 (en) | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of therapeutic peptides |
US11154238B2 (en) | 2015-08-07 | 2021-10-26 | Electroceuticals, Llc | Systems, methods and apparatuses for providing bioelectronic neurocode-based therapies to mammals |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4384995A (en) * | 1980-01-16 | 1983-05-24 | The Ohio State University | Antigenic modification of polypeptides |
US4201770A (en) * | 1973-05-07 | 1980-05-06 | The Ohio State University | Antigenic modification of polypeptides |
US4526716A (en) * | 1981-11-20 | 1985-07-02 | The Ohio State University | Antigenic modification of polypeptides |
US4691006A (en) * | 1983-03-04 | 1987-09-01 | Ohio State University | Antigenic modification of polypeptides |
US4302386A (en) * | 1978-08-25 | 1981-11-24 | The Ohio State University | Antigenic modification of polypeptides |
US4002738A (en) * | 1975-05-30 | 1977-01-11 | Abbott Laboratories | Treatment of specified neoplasias |
US4144031A (en) * | 1976-04-19 | 1979-03-13 | International Radioimmune Systems, Inc. | Cell test for detecting human chorionic gonadotropin |
US4116776A (en) * | 1976-04-19 | 1978-09-26 | International Radioimmune Systems, Inc. | Diagnostic blood test and kit for detecting human chorionic gonadotropin |
US4228127A (en) * | 1978-10-06 | 1980-10-14 | International Radioimmune Systems, Inc. | Kit for detecting human chorionic gonadotropin |
US4321260A (en) * | 1980-05-22 | 1982-03-23 | Ayerst, Mckenna & Harrison Inc. | Method of using gonadorelin for the treatment of benign prostatic hyperplasia |
US4692332A (en) * | 1985-01-18 | 1987-09-08 | Mcmichael John | Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms |
-
1996
- 1996-01-30 US US08/593,501 patent/US5610136A/en not_active Expired - Lifetime
- 1996-10-30 AU AU75278/96A patent/AU705524B2/en not_active Ceased
- 1996-10-30 DE DE69618578T patent/DE69618578T2/de not_active Expired - Lifetime
- 1996-10-30 WO PCT/US1996/017421 patent/WO1997027869A1/en active IP Right Grant
- 1996-10-30 AT AT96937823T patent/ATE211921T1/de not_active IP Right Cessation
- 1996-10-30 CA CA002216810A patent/CA2216810C/en not_active Expired - Fee Related
- 1996-10-30 EP EP96937823A patent/EP0817645B1/de not_active Expired - Lifetime
- 1996-10-30 JP JP9527607A patent/JP2971950B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5610136A (en) | 1997-03-11 |
DE69618578T2 (de) | 2003-01-23 |
AU7527896A (en) | 1997-08-22 |
EP0817645A1 (de) | 1998-01-14 |
DE69618578D1 (de) | 2002-02-21 |
AU705524B2 (en) | 1999-05-27 |
WO1997027869A1 (en) | 1997-08-07 |
EP0817645A4 (de) | 2000-11-29 |
CA2216810C (en) | 2005-04-26 |
EP0817645B1 (de) | 2002-01-16 |
CA2216810A1 (en) | 1997-08-07 |
JPH10507468A (ja) | 1998-07-21 |
JP2971950B2 (ja) | 1999-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
ATE211921T1 (de) | Verwendung von gonadotropin zur behandlung der gestartigen hypertrophie der prostata | |
EA200000220A1 (ru) | Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы | |
DE60023982D1 (de) | System zur Behandlung von benigner Prostatahyperplasie | |
ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
ATE313326T1 (de) | VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß | |
ATE207356T1 (de) | Verwendung von tiagabin zur behandlung von schlafstörungen | |
ATE300292T1 (de) | Thyroxin-analoge mit keiner signifikanten hormonellen aktivität zur behandlung von bösartigen tumoren | |
NO993396L (no) | Kinolin- og kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi | |
ATE222489T1 (de) | Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren | |
ATE370743T1 (de) | Verwendung von cetrorelix zur behandlung von benigne prostatahypertrophie und prostatakrebs | |
DE60032795D1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
ATE258796T1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
ATE311853T1 (de) | Verwendung von krillenzymen zur behandlung von zahnbelag | |
EP0646007A4 (de) | ||
DE69814444D1 (de) | Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation | |
ATE253061T1 (de) | Zur behandlung von krebs nützliche thiophen- und furan-2,5-dicarboxamide | |
NO994330L (no) | Metode for behandling av en tumor | |
ATE541565T1 (de) | Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus | |
ATE214272T1 (de) | Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz | |
ATE300295T1 (de) | Verwendung von baclofen zur behandlung von alkoholismus | |
ATE453402T1 (de) | Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis | |
MY118986A (en) | Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia | |
DE60313603D1 (de) | Pharmazeutische kombination zur behandlung von benigner prostatahyperplasie oder zur langzeitvorbeugung von akuter harnzurückhaltung | |
NO20003848D0 (no) | FremgangsmÕte ved behandling av folikkulært lymfom ved anvendelse av inhibitorer for lymfotoksin (LT)-veien |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |